BIP Announces Partnership with Domino Data Lab to Accelerate AI Impact Across the Life Sciences Value Chain

LONDON – BIP, a leading multinational consultancy firm, announces its partnership with Domino Data Lab, provider of the leading Enterprise AI platform trusted by over 20% of the Fortune 100, to jointly deliver solutions for rapidly and responsibly scaling enterprise AI innovation across Life Sciences and other key markets. BIP will provide professional services to help Domino customers rapidly scale AI innovation for a competitive advantage as part of this collaboration. BIP will also deliver pre-built templates and projects focused on accelerating life sciences use cases in Domino’s recently announced AI Hub.

Progress has been coming quickly in the clinical space, driven by open-source and AI innovation. Life Sciences leaders require the right AI technology and partnerships in the space to drive meaningful change and accelerate getting medicines and vaccines to patients who need them. Through this partnership, BIP will be able to further accelerate the value enterprise Life Sciences innovators gain from Domino’s highly scalable platform, taking advantage of its data science and statistical techniques, and centralising processes for research, regulated development, manufacturing, and commercialisation.

Michael Whitworth, Senior Partner, Life Sciences at BIP, comments: "We are thrilled to be reinforcing our expertise in AI through our unique partnership with Domino. This collaboration marks an important milestone in our journey to provide the Life Sciences sector with scalable, efficient, and cost-effective AI solutions. We’re already starting to see the important role AI is playing in developing crucial medical and scientific advances, and it’s imperative that our clients can unleash these benefits by applying AI at various stages of their value chain."

Caroline Phares, VP and Global Head of Life Sciences at Domino Data Lab, comments: “I am excited to be embarking on this ground-breaking journey as we unite the power of the Domino platform with BIP's expertise in AI. Together, we will empower our customers with cutting-edge technology and exceptional skills, setting new standards in innovation, enabling them to accelerate getting medicines and vaccines to a waiting patient population.”

BIP already brings a wealth of expertise in AI Governance, Data Governance and Data Science to the Life Sciences market, employing more than 5,000 people, across 13 countries. This partnership serves to reinforce its already strong credentials and ensure offerings stay at the cutting edge of technology.

Domino’s platform has a proven track record in the Life Sciences sector, enabling firms to efficiently build product pipelines, and conduct rapid analyses for regulatory submission, while ensuring governance and efficiency. The openness and flexibility of the Domino platform helps foster collaboration, establish best practice and track models in production to accelerate and scale the impact of AI across organisations.

-ENDS-

About BIP

BIP is a leading multinational consultancy firm employing over 5,000 people worldwide. Its professionals offer management consulting and business integration services and lead companies in researching and adopting disruptive technological solutions.

About Domino Data Lab

Domino Data Lab empowers the largest AI-driven enterprises to build and operate AI at scale. Domino’s Enterprise AI platform delivers the openness and flexibility AI teams want with the visibility and control the enterprise requires. Domino enables a repeatable and agile ML lifecycle for faster, responsible AI impact with lower costs. With Domino, global enterprises can develop better medicines, grow more productive crops, develop more competitive products, and more. Founded in 2013, Domino is backed by Sequoia Capital, Coatue Management, NVIDIA, Snowflake, and other leading investors. Learn more at www.domino.ai.